P375 Faecal calprotectin variation after induction therapy with infliximab to predict clinical, endoscopic and ultrasonographic remission in Crohn’s disease patients
Joana Revés(Hospital Beatriz Ângelo), Carolina Palmela(Hospital Beatriz Ângelo), Maria João Ferreira, Maria João Moreira(Hospital da Senhora da Oliveira Guimarães), Rui Dinis Sousa(Centro Hospitalar de Lisboa Ocidental), José Cotter(Hospital da Senhora da Oliveira Guimarães), Marta Freitas(Hospital da Senhora da Oliveira Guimarães), Ana Teresa Caldeira(University of Macau), Francisca Dias de Castro(Hospital da Senhora da Oliveira Guimarães), C Macedo(Hospitais da Universidade de Coimbra), Guilherme Macedo(Hospital de São João), Joana Torres(University of Lisbon), B Morão(Hospital Beatriz Ângelo), L Glória(Hospital Beatriz Ângelo), Fábio Pereira(Universidade Federal de Alfenas), Natacha Abreu(Hospital Dr. Nélio Mendonça), Cássio do Nascimento(Universidade de São Paulo), C Frias Gomes(Hospital Beatriz Ângelo), T Cúrdia Gonçalves(Hospital da Senhora da Oliveira Guimarães), Rosa Coelho(Hospital de São João)
Cited by 0
Related Papers
ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment
|Journal of Crohn s and Colitis|2019|1.4k
ECCO Guidelines on Therapeutics in Crohn’s Disease: Surgical Treatment
|Journal of Crohn s and Colitis|2019|1.1k
KDM6B/JMJD3 histone demethylase is induced by vitamin D and modulates its effects in colon cancer cells
|Human Molecular Genetics|2011|182